73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS

A top-down study of isogenic human non-metastatic and metastatic colorectal cancer cell lines

by Bob Yirka , Medical XpressSchematic of the experimental design. (A) Schematic design of the TDP study of metastatic (SW620) and nonmetastatic (SW480) CRC cells using CZE-ESI-MS/MS and LC-CZE-ESI-MS
Decrease noted in lung cancer cases over past five years

Decrease noted in lung cancer cases over past five years

by Elana Gotkine HealthDay ReporterThe number of new cases of lung cancer has decreased over the last five years, but screening rates are still low, according to a report published by the American Lun

Decrease noted in lung cancer cases over past five years

by Elana Gotkine HealthDay ReporterThe number of new cases of lung cancer has decreased over the last five years, but screening rates are still low, according to a report published by the American Lun
Study suggests liquid biopsy could detect and monitor aggressive small-cell lung cancer

Study suggests liquid biopsy could detect and monitor aggressive small-cell lung cancer

byFred Hutchinson Cancer CentercfDNA sequencing for integrated mutation detection and inference of tumor TF activity and gene expression. Credit:Science Advances(2024). DOI: 10.1126/

Study suggests liquid biopsy could detect and monitor aggressive small-cell lung cancer

byFred Hutchinson Cancer CentercfDNA sequencing for integrated mutation detection and inference of tumor TF activity and gene expression. Credit:Science Advances(2024). DOI: 10.1126/
Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

byUCLA Engineering Institute for Technology AdvancementVirtual HER2 staining of unlabeled breast tissue sections using deep learning. Credit: Ozcan Lab @ UCLA.Breast cancer is one the leading ca

Deep learning–based virtual staining of tissue facilitates rapid assessment of breast cancer biomarker

byUCLA Engineering Institute for Technology AdvancementVirtual HER2 staining of unlabeled breast tissue sections using deep learning. Credit: Ozcan Lab @ UCLA.Breast cancer is one the leading ca
Resistance (exercise) is far from futile: The unheralded benefits of weight training

Resistance (exercise) is far from futile: The unheralded benefits of weight training

by Stuart Phillips,The ConversationCredit: CC0 Public DomainEveryone can agree that exercise is healthy. Among its many benefits, exercise improves heart and brain function, aids in controlling

Resistance (exercise) is far from futile: The unheralded benefits of weight training

by Stuart Phillips,The ConversationCredit: CC0 Public DomainEveryone can agree that exercise is healthy. Among its many benefits, exercise improves heart and brain function, aids in controlling
Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene

Novel treatment regimen for FLT3-mutated acute myeloid leukemia shows promise in new study

by Roswell Park Comprehensive Cancer CenterAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainUp to 30% of patients newly diagnosed with acute myeloid leukemia (AML) have an FLT3 gene
Study reveals why testicular cancer is so responsive to chemo

Study reveals why testicular cancer is so responsive to chemo

by Cornell UniversityA low magnification image of a germ cell tumor, called a teratocarcinoma, from a new mouse model developed to study testicular cancer. A cluster of cancer stem cells, termed

Study reveals why testicular cancer is so responsive to chemo

by Cornell UniversityA low magnification image of a germ cell tumor, called a teratocarcinoma, from a new mouse model developed to study testicular cancer. A cluster of cancer stem cells, termed
Two genes slow down the development of intestinal tumors

Two genes slow down the development of intestinal tumors

byThe Francis Crick InstituteImage of two intestinaltumours, one a control (top) and one with the genes NEDD4 and NEDD4L deleted (bottom). Credit: The Francis Crick InstituteBenign i

Two genes slow down the development of intestinal tumors

byThe Francis Crick InstituteImage of two intestinaltumours, one a control (top) and one with the genes NEDD4 and NEDD4L deleted (bottom). Credit: The Francis Crick InstituteBenign i
Limited-Stage Small Cell Lung Cancer Treatment

Limited-Stage Small Cell Lung Cancer Treatment

Limited-Stage Small Cell Lung Cancer TreatmentUnique Treatment Approaches for Early-Stage and Locally Advanced Lung CancersByJennifer WelshUpdated on October 10, 2023Medically review

Limited-Stage Small Cell Lung Cancer Treatment

Limited-Stage Small Cell Lung Cancer TreatmentUnique Treatment Approaches for Early-Stage and Locally Advanced Lung CancersByJennifer WelshUpdated on October 10, 2023Medically review
Survival 21 percent a year after ICU discharge for blood cancer patients

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl

Survival 21 percent a year after ICU discharge for blood cancer patients

by Elana GotkineFor hematologic malignancy (HM) patients admitted to the intensive care unit (ICU), survival is 49 percent at seven days and 21 percent at 12 months, according to a study published onl